PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
28,138,378
Share change
-2,909,553
Total reported value
$73,437,206
Put/Call ratio
42%
Price per share
$2.61
Number of holders
47
Value change
-$9,079,026
Number of buys
23
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q4 2021

As of 31 Dec 2021, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,138,378 shares. The largest 10 holders included NEA Management Company, LLC, Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, VANGUARD GROUP INC, JOHNSON & JOHNSON, BlackRock Inc., ExodusPoint Capital Management, LP, and DAFNA Capital Management LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.